Pain of Patients, Suffering of Caregivers: Evaluation of the Benefit of Full Consciousness Meditation in Oncology

Overview

The study is based on the realization of a meditation program associating patients, caregivers and control subjects

Full Title of Study: “Pain of Patients, Suffering of Caregivers: Evaluation of the Benefit of Full Consciousness Meditation in Oncology to Improve Stress and Quality of Life With Joint Participation of “Witness / Patient / Caregivers””

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: February 11, 2021

Interventions

  • Behavioral: Meditation
    • Meditation sessions will take place over 12 weekly sessions of 1.5 hours

Arms, Groups and Cohorts

  • Experimental: MEDITATION
    • Meditation sessions will take place over 12 weekly sessions of 1.5 hours. A retreat (3 hours) will be realized after the 9th session

Clinical Trial Outcome Measures

Primary Measures

  • Evaluate the adherence of all participants to the full meditation program
    • Time Frame: 3 months after the beginning of program
    • Proportion of participants adhering to the full meditation program (13 sessions)

Participating in This Clinical Trial

Inclusion criteria for all participants (patients, caregivers and control subjects)

  • Participants aged 18 or over – Curious and motivated participant to participate in the program – Participant with no current or previous experience of regular or intensive practice of meditation or a comparable practice. The practice is considered regular and / or intensive if: – it occurs more than one day per week for more than 6 consecutive months over the last 10 years, – and / or in case of more than 5 consecutive days of intensive practice (internship or retirement) in the last 10 years, – and / or more than 25 consecutive days of (cumulative) retirement over the last 10 years. – Participant available to follow the full meditation program (3 month period) – Participant agreeing to participate by signing the study information note – Participant able to understand, speak and read French – Patient capable of using digital media and having an internet connection Patient-specific criteria (target population) – Patients with cancer, – State of health compatible with the study meditation program – Patient affiliated to a social Health sytem Caregiver-specific criteria – All medical and / or paramedical staff of the sponsor Center in contact with patients (doctors, nurse, caregiver, radiotherapy manipulator MERM) Criteria specific to the control population – Any voluntary person not belonging to the two categories above Exclusion Criteria:

For all participants

  • Participant with significant vulnerability factors dependence on alcohol and drugs, severe depression, severe social anxiety, recent mourning etc.). – Participant who cannot submit to the follow-up of the trial for geographic, social or psychopathological reasons For patients – Very advanced stage of cancer disease with life-threatening commitment, – Participant deprived of liberty or under guardianship For control subjects – Nursing staff, regardless of their place of practice

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Centre Francois Baclesse
  • Collaborator
    • Fondation de France
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.